Literature DB >> 6408002

In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.

R U Sorensen, J D Klinger, H A Cash, P A Chase, D G Dearborn.   

Abstract

Human lymphocyte proliferation is inhibited in vitro in the presence of killed Pseudomonas aeruginosa or cell-free P. aeruginosa culture supernatants. A comparison of culture supernatants obtained under similar conditions from Staphylococcus aureus, Escherichia coli, P. aeruginosa, and Pseudomonas cepacia strains demonstrated that all P. aeruginosa supernatants were strongly inhibitory, whereas supernatants from other bacteria were mildly inhibitory or not inhibitory at all. These P. aeruginosa inhibitors prevent proliferative responses of resting cells upon mitogen activation and decrease [3H]thymidine uptake when added to human lymphocytes undergoing active proliferation in culture. The inhibitory effect is reversible and not due to cytotoxicity. Most of the inhibitory activity present in crude supernatants was detected in ultrafiltrates of molecular weights below 2,000. Purified P. aeruginosa pyocyanine, a low-molecular-weight phenazine pigment present in culture supernatant, was strongly inhibitory for lymphocyte proliferation. Extraction of pyocyanine and phenazine pigments from inhibitory P. aeruginosa supernatants eliminated their inhibitory activity. Inhibitors were recovered from reverse-phase chromatographic cartridges by both chloroform and methanol elution, indicating that pyocyanine and other phenazine pigments present in P. aeruginosa supernatants are responsible for the inhibition of lymphocyte proliferation. In addition to the identification of phenazine pigments as lymphocyte proliferation inhibitors, several criteria ruled out major contributions of P. aeruginosa polysaccharide, exotoxin A, and proteases to this phenomenon. P. aeruginosa strains selected for very low protease production or for very low exotoxin A production produced supernatants as inhibitory for lymphocyte proliferation as supernatants obtained from clinical P. aeruginosa isolates. Purified P. aeruginosa lipopolysaccharide and protease preparations failed to induce reversible lymphocyte proliferation inhibition. Finally, heat inactivation of P. aeruginosa supernatants at 100 degrees C for 60 min inactivates exotoxin A and proteases but produced only a moderate decrease of the inhibitory activity for lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408002      PMCID: PMC264781          DOI: 10.1128/iai.41.1.321-330.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Opposing effects of mitogenic and nonmitogenic lectins on lymphocyte activation. Evidence that wheat germ agglutinin produces a negative signal.

Authors:  W C Greene; C M Parker; C W Parker
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

3.  Changing patterns of malaria in the United States.

Authors:  J J Gibson; R E Brodsky; M G Schultz
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

4.  The site of the activity of extracellular products of Pseudomonas aeruginosa in the electron-transport chain in mammalian cell respiration.

Authors:  A V Armstrong; D E Stewart-Tull
Journal:  J Med Microbiol       Date:  1971-05       Impact factor: 2.472

5.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

6.  Simultaneous production of three phenazine pigments by Pseudomonas aeruginosa Mac 436.

Authors:  P C Chang; A C Blackwood
Journal:  Can J Microbiol       Date:  1969-05       Impact factor: 2.419

7.  The purification and characterization of L-histidine ammonia-lyse (Pseudomonas).

Authors:  M M Rechler
Journal:  J Biol Chem       Date:  1969-02-25       Impact factor: 5.157

8.  Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

9.  The effect of 1-hydroxyphenazine and pyocyanin from Pseudomonas aeruginosa on mammalian cell respiration.

Authors:  D E Stewart-Tull; A V Armstrong
Journal:  J Med Microbiol       Date:  1972-02       Impact factor: 2.472

10.  Characterisation of the Pseudomonas aeruginosa factor that inhibits mouse-liver mitochondrial respiration.

Authors:  A V Armstrong; D E Stewart-Tull; J S Roberts
Journal:  J Med Microbiol       Date:  1971-05       Impact factor: 2.472

View more
  24 in total

1.  The purification, crystallization and preliminary structural characterization of PhzM, a phenazine-modifying methyltransferase from Pseudomonas aeruginosa.

Authors:  Neelakshi Gohain; Linda S Thomashow; Dmitri V Mavrodi; Wulf Blankenfeldt
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-11

2.  The purification, crystallization and preliminary structural characterization of FAD-dependent monooxygenase PhzS, a phenazine-modifying enzyme from Pseudomonas aeruginosa.

Authors:  Neelakshi Gohain; Linda S Thomashow; Dmitri V Mavrodi; Wulf Blankenfeldt
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-09-30

3.  Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

Authors:  K B Adler; D D Hendley; G S Davis
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

Review 4.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Inhibitory and stimulatory effects of Pseudomonas aeruginosa pyocyanine on human T and B lymphocytes and human monocytes.

Authors:  A J Ulmer; J Pryjma; Z Tarnok; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

Review 6.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

7.  Simultaneous production of rhamnolipids, 2-alkyl-4-hydroxyquinolines, and phenazines by clinical isolates of Pseudomonas aeruginosa.

Authors:  B C Smeal; L Bender; D L Jungkind; A T Hastie
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

8.  Nebulized thiocyanate improves lung infection outcomes in mice.

Authors:  J D Chandler; E Min; J Huang; D P Nichols; B J Day
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 9.  Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes.

Authors:  Leland S Pierson; Elizabeth A Pierson
Journal:  Appl Microbiol Biotechnol       Date:  2010-03-30       Impact factor: 4.813

Review 10.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.